L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors
ATC group of level 4 – chemical subgroup · in plain English: cancer medicines
This site has the patient leaflet or the SPC of 13 medicines in this group and its subgroups.
- 11 prescription only (POM)
- 2 no longer supplied or not available
Place in the ATC classification
How to read ATC codes – what the levels mean and what a code does not tell you.
- L Antineoplastic and immunomodulating agents 1,815 medicines
- L01 Antineoplastic agents 1,028 medicines
- L01X Other antineoplastic agents 225 medicines
-
L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors 13 medicines
- L01XK01 olaparib 3 medicines
- L01XK02 niraparib 2 medicines
- L01XK03 rucaparib 3 medicines
- L01XK04 talazoparib 5 medicines
-
L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors 13 medicines
- L01X Other antineoplastic agents 225 medicines
- L01 Antineoplastic agents 1,028 medicines
1 more subgroup has no medicine with a leaflet on this site.
Active substances in the group
- Niraparib 2 medicines
- Olaparib 3 medicines
- Rucaparib 3 medicines
- Talazoparib 5 medicines
Medicines in the group and its subgroups
Other groups of the same level
- L01XA Platinum compounds, antineoplastic drugs 11 medicines
- L01XB Methylhydrazines, antineoplastics 1 medicine
- L01XC Monoclonal antibodies, antineoplastic 73 medicines
- L01XD Sensitizers used in photodynamic/radiation therapy 10 medicines
- L01XF Retinoids for cancer treatment 2 medicines
- L01XG Proteasome inhibitors, antineoplastic agent 43 medicines
- L01XH Histone deacetylase (HDAC) inhibitors 3 medicines
- L01XJ Hedgehog pathway inhibitors 4 medicines
- L01XX Other antineoplastic agents 59 medicines
- L01XY Combinations of antineoplastic agents 4 medicines
Other names of the ATC group
- German: L01XK Poly-ADP-Ribose-Polymerase (PARP)-Inhibitoren
- German: L01XK Poly-ADP-Ribose-Polymerase (PARP)-Inhibitoren
- Italian: L01XK Inibitori della poli (ADP-ribose) polimerasi (PARP)
- Turkish: L01XK Poli (ADP-riboz) polimeraz (PARP) inhibitörleri
- German (Switzerland): L01XK Poly-ADP-Ribose-Polymerase (PARP)-Inhibitoren
- Italian (Switzerland): L01XK Ibibitori della poli polimerasi
- English (Canada): L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors
- French (Canada): L01XK Inhibiteurs de la poly(ADP-ribose) polymérase (PARP)
- Slovak: L01XK Inhibítory poly(ADP-ribóza) (PARP) polymerázy
- Spanish: L01XK Inhibidores de la poli (adp-ribosa) polimerasa (parp)
- Czech: L01XK Inhibitory poly (ADP-RIBÓZO) polymerázy (PARP)
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L01XK
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.
